Augmentation of IgM antibody to gp43 tumor-associated antigen peptide by melanoma cell vaccine

Journal of Clinical Immunology

Volumn 18, Issue 4, 1998, Pages 299-305

  Takahashi, Takenori ^a   Conforti, Arnold ^a   Kikumoto, Yoshikazu ^a   Hoon, Dave S B ^a   Morton, Donald L ^a   Irie, Reiko F ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

IgM antibody; Melanoma; Peptide antigen; Prognosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELANOMA VACCINE; TUMOR ANTIGEN;

ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MELANOMA; METASTASIS; PRIORITY JOURNAL; VACCINATION;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; HUMANS; IMMUNOGLOBULIN M; MELANOMA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PEPTIDES; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 0031878123     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027342024618     Document Type: Article

References (13)

1. Morton DL, Foshag LJ, Hoon DSB, Nizze JA, Famatiga E, Wanek LA, Chang C, Davtyan DG, Gupta RK, Elashoff R, Irie RF: Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg 216:468-482, 1992
2. Oka T, Kikumoto Y, Itakura K, Morton DL, Irie RF: A human monoclonal antibody identified an immunoreactive tetrapeptide sequence (Lys-Try-Gln-Ile) in 43-kD protein of human melanoma. Cancer Res 54:3511-3515, 1994
3. Morioka N, Kikumoto Y, Oka T, Hoon DSB, Morton DL, Irie RF: A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patients. J Immunol 153:5650-5658, 1994
4. Takahashi T, Irie RF, Morton DL, Hoon DSB: Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients. Cell Immunol 178:162-171, 1997
5. Kikumoto Y, Oka T, Cao J-n, Sze L, Irie RF: Peptide with carboxyl terminal sequence of alanine-proline: Detection by a human monoclonal antibody. Hybridoma 14:45-50, 1995
6. Takahashi T, Irie RF, Nishinaka Y, Hoon DSB: 707-AP peptide recognized by human antibody induces HLA-A2 restricted CTL killing of melanoma. Clin Cancer Res 13:1363-1370, 1997
7. Shichijo S, Tsunosue R, Kubo K, Kuramoto T, Tanaka Y, Hayashi A, Itoh K: Establishment of an enzyme-linked immunosorbent assay (ELISA) for measuring cellular MAGE-4 protein on human cancers. J Immunol Methods 186:137-149, 1995
8. Devaux C, Juin M, Mansuelle P, Granier C: Fine molecular analysis of the antigenicity of the androctonus australis hector scorpion nerutoxin H II: A new antigenic epitope disclosed by the pepscan method. Mol Immunol 30:1061-1068, 1993
9. Manivel V, Panda SK, Rao KVS: Identification of a new group-specific determinant on hepatitis B surface antigen with a synthetic peptide. J Immunol 149:2082-2088, 1992
10. Lis H, Sharon N: Protein glycosylation: Structural and functional aspects. Eur J Biochem 218:1-27, 1993
11. Norgard KE, Han H, Powell L, Kriegler M, Varki A, Varki NM: Enhanced interaction or L-selection with the high endothelial venule ligand via selectively oxidized sialic acids. Proc Natl Acad Sci USA 90:1068-1072, 1993
12. Corfield AP, Schauer R: In Sialic Acids, R Schauer (ed). Springer-Verlag, Wien New York, 1983, pp 224-238
13. Irie RF, Sze LL, Saxton RE: Human antibody to OFA-1, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines. Proc Natl Acad Sci USA 79:5666-5670, 1982